|
NFATC2IP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.80210005093795E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.4152000000075E-05 |
| Normal-vs-Stage2 |
1.501590E-02 |
| Normal-vs-Stage3 |
1.735930E-02 |
| Normal-vs-Stage4 |
3.491000E-01 |
| Stage1-vs-Stage2 |
2.935600E-01 |
| Stage1-vs-Stage3 |
5.509400E-01 |
| Stage1-vs-Stage4 |
7.455200E-01 |
| Stage2-vs-Stage3 |
2.433800E-01 |
| Stage2-vs-Stage4 |
4.253600E-01 |
| Stage3-vs-Stage4 |
9.789800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.08250000074861E-08 |
| Normal-vs-AfricanAmerican |
5.659100E-03 |
| Normal-vs-Asian |
4.223900E-02 |
| Caucasian-vs-AfricanAmerican |
1.965410E-01 |
| Caucasian-vs-Asian |
6.289600E-01 |
| AfricanAmerican-vs-Asian |
9.689600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44749999764215E-08 |
| Normal-vs-Female |
1.790630E-04 |
| Male-vs-Female |
7.021400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.316100E-02 |
| Normal-vs-Extreme_Weight |
1.395490E-03 |
| Normal-vs-Obese |
4.02160000000373E-05 |
| Normal-vs-Extreme_Obese |
2.931600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.156000E-01 |
| Normal_Weight-vs-Obese |
1.127800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.501800E-01 |
| Extreme_Weight-vs-Obese |
9.042100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.430200E-01 |
| Obese-vs-Extreme_Obese |
3.482800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.217900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.47230000413501E-08 |
| Normal-vs-Age(61-80Yrs) |
2.14939999999553E-05 |
| Normal-vs-Age(81-100Yrs) |
8.303400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.773000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.615000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.521000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.500440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.209900E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.157700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.20179985355173E-10 |
| Normal-VS-Type2 PRCC |
1.613400E-01 |
| Normal-VS-KIRP CIMP |
1.181890E-02 |
| Normal-VS-Unclassified PRCC |
1.844170E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.63429999999942E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.598800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.332800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.698800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.483870E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.891790E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.104800E-03 |
| Normal-vs-N1 |
1.700320E-02 |
| Normal-vs-N2 |
4.541000E-01 |
| N0-vs-N1 |
5.039800E-01 |
| N0-vs-N2 |
2.339600E-01 |
| N1-vs-N2 |
1.827230E-01 |
|
|
